Method for determining MIF content

US6998238B2 · kind B2 · utility

Assignee

• Cytokine PharmaSciences, Inc. · US

Inventors

• Richard J. Bucala · New York, US
• Robert A. Mitchell · Fort Mill, US
• Jurgen Bernhagen · Tübingen, DE
• Thierry Calandra · New York, US
• Anthony Cerami · Stratford, US

Key dates

• Filing date: Apr 25, 2000
• Grant date: Feb 14, 2006
• Expiry date: Apr 25, 2020

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A diagnostic method for determining MIF protein content in a sample using a direct or an indirect detection technique and wherein MIF is a human MIF protein having a molecular weight of approximately 12.5 kDa.